SRP374577 PRJNA836926 GSE202672 Effect of HAPLN1-PTR1 on RPMI8226 multiple myeloma cells To investigate the role of HAPLN1 in multiple myeloma, we treated RPMI8226 multiple myeloma cells with recombinant HAPLN1-PTR1. We then performed gene expression profiling analysis using data obtained from RNA-seq. Overall design: Comparative gene expression profiling analysis of RNA-seq data for RPMI8226 multiple myeloma cells treated with 100 nM GST (control) or GST-PTR1 (experimental group) for 6 h. GSE202672 pubmed 36480501 pubmed 37647592